Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:almaMater |
gptkb:St_Bartholomew's_Hospital_Medical_College
gptkb:University_of_Oxford |
| gptkbp:birthYear |
1965
|
| gptkbp:employer |
gptkb:University_of_Oxford
|
| gptkbp:field |
paediatric infection and immunity
|
| gptkbp:fullName |
Sir Andrew John Pollard
|
| gptkbp:honor |
knighted
|
| gptkbp:knownFor |
COVID-19 vaccine development
|
| gptkbp:memberOf |
gptkb:Academy_of_Medical_Sciences
gptkb:Royal_College_of_Physicians |
| gptkbp:nationality |
British
|
| gptkbp:notableWork |
gptkb:Oxford–AstraZeneca_COVID-19_vaccine
|
| gptkbp:occupation |
gptkb:professor
gptkb:immunologist |
| gptkbp:title |
Director of the Oxford Vaccine Group
|
| gptkbp:bfsParent |
gptkb:2022_New_Year_Honours
gptkb:Bubba_Pollard |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Andrew Pollard
|